Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02640079 · ClinicalTrials.gov registry record · NA
A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea
A NA study of Pain Catastrophizing and Primary Dysmenorrhea, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT02640079: Completed NA study of Pain Catastrophizing and Primary Dysmenorrhea, sponsored by University of California, Los Angeles.
NCT02640079 is a NA study of Pain Catastrophizing and Primary Dysmenorrhea that has completed, run by University of California, Los Angeles. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02640079, a NA study of Pain Catastrophizing and Primary Dysmenorrhea, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the feasibility and efficacy of a brief group therapy treatment program focused on reducing pain catastrophizing in adolescents and young adults (ages 16-25) with menstrual pain.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive behavioral therapy
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-11 |
| Phase | NA |
What the finished NCT02640079 record still lists
NCT02640079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Pain Catastrophizing appearing as the primary indexed condition, and to 1 intervention - of which Cognitive behavioral therapy is the first listed.
NCT02640079 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02640079 about?
NCT02640079 is a clinical study titled "A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea". The purpose of this study is to test the feasibility and efficacy of a brief group therapy treatment program focused on reducing pain catastrophizing in adolescents and young adults (ages 16-25) with menstrual pain.
What is the current status of trial NCT02640079?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-01. Estimated completion is 2017-11.
What conditions does trial NCT02640079 study?
This clinical trial studies the following conditions: Pain Catastrophizing, Primary Dysmenorrhea.
What interventions are being tested in trial NCT02640079?
The interventions under investigation include: Cognitive behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02640079?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02640079 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain Catastrophizing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02640079's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia